These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 33795132
21. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lehtinen M, Paavonen J, Wheeler CM, Jaisamrarn U, Garland SM, Castellsagué X, Skinner SR, Apter D, Naud P, Salmerón J, Chow SN, Kitchener H, Teixeira JC, Hedrick J, Limson G, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, De Carvalho NS, Germar MJ, Peters K, Mindel A, De Sutter P, Bosch FX, David MP, Descamps D, Struyf F, Dubin G, HPV PATRICIA Study Group. Lancet Oncol; 2012 Jan; 13(1):89-99. PubMed ID: 22075171 [Abstract] [Full Text] [Related]
23. Defining hrHPV genotypes in cervical intraepithelial neoplasia by laser capture microdissection supports reflex triage of self-samples using HPV16/18 and FAM19A4/miR124-2 methylation. Leeman A, Ebisch RMF, Kasius A, Bosgraaf RP, Jenkins D, van de Sandt MM, de Strooper LMA, Heideman DAM, Snijders PJF, Massuger LFAG, Bekkers RLM, Meijer CJLM, van Kemenade FJ, Quint WGV, Melchers WJG. Gynecol Oncol; 2018 Nov; 151(2):311-318. PubMed ID: 30219239 [Abstract] [Full Text] [Related]
24. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada. Coutlée F, Ratnam S, Ramanakumar AV, Insinga RR, Bentley J, Escott N, Ghatage P, Koushik A, Ferenczy A, Franco EL. J Med Virol; 2011 Jun; 83(6):1034-41. PubMed ID: 21503917 [Abstract] [Full Text] [Related]
26. Human papillomavirus infections among women with cervical lesions and cervical cancer in Eastern China: genotype-specific prevalence and attribution. Zhang L, Bi Q, Deng H, Xu J, Chen J, Zhang M, Mu X. BMC Infect Dis; 2017 Jan 31; 17(1):107. PubMed ID: 28143439 [Abstract] [Full Text] [Related]
29. Co-infections of HPV16/18 with other high-risk HPV types and the risk of cervical carcinogenesis: A large population-based study. Wu P, Xiong H, Yang M, Li L, Wu P, Lazare C, Cao C, Gao P, Meng Y, Zhi W, Lin S, Hu J, Wei J, Ma D, Liu J, Yin P, Xing H. Gynecol Oncol; 2019 Dec 31; 155(3):436-443. PubMed ID: 31604662 [Abstract] [Full Text] [Related]
30. Management of HPV-positive women in cervical screening using results from two consecutive screening rounds. Polman NJ, Veldhuijzen NJ, Heideman DAM, Snijders PJF, Meijer CJLM, Berkhof J. Int J Cancer; 2019 May 01; 144(9):2339-2346. PubMed ID: 30565673 [Abstract] [Full Text] [Related]
31. Fraction of high-grade cervical intraepithelial lesions attributable to genotypes targeted by a nonavalent HPV vaccine in Galicia, Spain. Perez S, Iñarrea A, Pérez-Tanoira R, Gil M, López-Díez E, Valenzuela O, Porto M, Alberte-Lista L, Peteiro-Cancelo MA, Treinta A, Carballo R, Reboredo MC, Alvarez-Argüelles ME, Purriños MJ. Virol J; 2017 Nov 06; 14(1):214. PubMed ID: 29110680 [Abstract] [Full Text] [Related]
35. Incidence risk of cervical intraepithelial neoplasia 3 or more severe lesions is a function of human papillomavirus genotypes and severity of cytological and histological abnormalities in adult Japanese women. Hosaka M, Fujita H, Hanley SJ, Sasaki T, Shirakawa Y, Abiko M, Kudo M, Kaneuchi M, Watari H, Kikuchi K, Sakuragi N. Int J Cancer; 2013 Jan 15; 132(2):327-34. PubMed ID: 22729477 [Abstract] [Full Text] [Related]
37. [Changes in genotype prevalence of human papillomavirus over 10-year follow-up of a cervical cancer screening cohort]. Dong L, Hu SY, Zhang Q, Feng RM, Zhang L, Zhao XL, Ma JF, Shi SD, Zhang X, Pan QJ, Zhang WH, Qiao YL, Zhao FH. Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jan 10; 38(1):20-25. PubMed ID: 28100371 [Abstract] [Full Text] [Related]